Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The target "novel transcript, sense intronic to ROS1 and RP1-179P9.3" (ENSG00000298487) refers to a putative RNA transcript annotated within the intronic regions of the ROS1 and RP1-179P9.3 loci. No evidence supports its translation into a protein or its functional characterization as a therapeutic target. It is not recognized in major databases as a gene with known molecular, biological, or clinical roles. The entry likely represents a computational or experimental annotation of an uncharacterized non-coding RNA or a misannotation, not a canonical drug target, enzyme, transporter, or receptor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, sense intronic to ROS1 and RP1-179P9.3.